Acute seizure management in children

Pediatric Health

Volumn 3, Issue 6, 2009, Pages 543-549

  Kirmani, Batool F ^a  

^a SCOTT AND WHITE MEMORIAL HOSPITAL   (United States)

Author keywords

Acute repetitive seizure; Benzodiazepine; Diazepam rectal gel; Electroencephalography; Fosphenytoin; Intranasal midazolam; Levetiracetam; Phenobarbital; Phenytoin; Status epilepticus; Valproate

Indexed keywords

BENZODIAZEPINE DERIVATIVE; DIAZEPAM; ETIRACETAM; FOSPHENYTOIN SODIUM; LORAZEPAM; MIDAZOLAM; PHENOBARBITAL; PHENYTOIN; VALPROIC ACID;

ABSENCE OF SIDE EFFECTS; ACUTE REPETATIVE SEIZURE; ACUTE REPETITIVE SEIZURE; CHILD; CLINICAL TRIAL; CONTINUOUS INFUSION; DIZZINESS; DRUG DISTRIBUTION; DRUG EFFICACY; DRUG HALF LIFE; DRUG MEGADOSE; DRUG METABOLISM; DRUG SAFETY; DRUG TOLERABILITY; EPILEPTIC STATE; HEART ARRHYTHMIA; HUMAN; HYPOTENSION; INJECTION SITE IRRITATION; LIVER TOXICITY; LOADING DRUG DOSE; PARESTHESIA; PATHOPHYSIOLOGY; PHLEBITIS; PRURITUS; RESPIRATION DEPRESSION; REVIEW; SEDATION; SEIZURE; SIDE EFFECT; SINGLE DRUG DOSE;

EID: 73949100798     PISSN: 17455111     EISSN: None     Source Type: Journal    
DOI: 10.2217/phe.09.59     Document Type: Review

References (50)

1. [No authors listed]: Treatment of convulsive status epilepticus. Recommendations of the Epilepsy Foundation of America's Working Group on status epilepticus. JAMA 270 (7), 854-859 (1993).
2. Lowenstein DH, Bleck T, Macdonald RL: It's time to revise the defnition of status epilepticus. Epilepsia 40 (1), 120-122 (1999).
3. Pellock JM: Status Epilepticus. In: Neurologic Emergencies in Infancy and Childhood. 2nd Edition. Pellock JM, Myer FC (Eds). Demos, NY, USA, 167 (1993).
4. Pellock JM: Status epilepticus in children: update and review. J. Child Neurol. 9 (Suppl. 2), S27-S35 (1994).
5. Towne AR, Pellock JM, Ko D, DeLorenzo RJ: Determinants of mortality in status epilepticus. Epilepsia 35, 27-34 (1994).
6. DeLorenzo RJ, Hauser WA, Towne AR et al.: A prospective, population-based epidemiologic study of status epilepticus in Richmond, Virginia. Neurology 46 (4), 1029-1035 (1996). •Study demonstrating that the incidence of status epilepticus (SE) was 41 patients per year per 100,000 population.
7. Treiman DM: Electroclinical features of status epilepticus. J. Clin. Neurophysiol. 12 (4) 343-362 (1995).
8. DeLorenzo RJ, Kirmani B, Deshpande LS et al.: Comparisons of the mortality and clinical presentations of status epilepticus in private practice community and university hospital settings in Richmond, Virgini. Seizure 18 (6), 405-411 (2009). •First direct prospective comparison of SE present in university and private practice community hospital settings in the Richmond area, which demonstrated that the mortality was highest in the elderly population while the pediatric population had low mortality in both clinical settings.
9. Shovron SD: Status Epilepticus: Its Clinical Features and Treatment in Children and Adults. Cambridge University Press, Cambridge, UK (1994).
10. Pellock JM: Management of acute seizure episodes. Epilepsia 39 (Suppl. 1), S28-S35 (1998). •Comprehensive review of management of acute seizure episodes in adults and children.
11. Treiman D: Pharmacokinetics and clinical use of benzodiazepines in the management of status epilepticus. Epilepsia 30, 4-10 (1989).
12. Alldredge BK, Gelb AM, Isaacs SM et al.: A comparison of lorazepam, diazepam, and placebo for the out of hospital status epilepticus. N. Engl. J. M Ed. 345, 631-637 (2001).
13. Appleton R, Choonara I, Martland T, Phillips B, Scott R, Whitehouse W: The treatment of convulsive status epilepticus in children. The Status Epilepticus Working Party, Members of the Status Epilepticus Working Party. Arch. Dis. Child 83, 415-419 (2000).
14. Leppik IE, Derivan AT, Homan RW, Walker J, Ramsay RE, Patrick B: Double-blind study of lorazepam and diazepam in status epilepticus. JAMA 249, 1452-1454 (1983).
15. Lowenstein DH, Alldredge BK: Status epilepticus. N. Engl. J. M Ed. 338, 970-976 (1998).
16. Camfeld CS, Camfeld PR, Smith E, Dooley JM: Home use of rectal diazepam to prevent status epilepticus in children with convulsive disorders. J. Child Neurol. 4, 125-126 (1989).
17. Shaner DM, McCurdy SA, Herring MO, Gabor AJ: Treatment of status epilepticus: a prospective comparison of diazepam and phenytoin versus phenobarbital and optional phenytoin. Neurology 38, 202-207 (1988).
18. Treiman DM, Meyers PD, Walton NY et al.: A comparison of four treatments for generalized convulsive status epilepticus. Veterans Affairs Status Epilepticus Cooperative Study Group. N. Engl. J. M Ed. 339, 792-798 (1998).
19. Dooley JM: Rectal use of benzodiazepines. Epilepsia 39, S24-S27 (1998).
20. Kriel RL, Cloyd JC, Hadsall RS, Carlson AM, Floren KL, Jones-Saete CM: Home use of rectal diazepam for cluster and prolonged seizures: effcacy, adverse reactions, quality of life, and cost analysis. Pediatr. Neurol. 7, 13-17 (1991).
21. Galvin GM, Jelinek GA: Successful treatment of 75 patients in SE with IV midazolam. Emerg. M Ed. 4, 77-81 (1992).
22. Yoshikawa H, Yamazaki S, Abe T, Oda Y: Midazolam as a frst line agent for status epilepticus in children. Brain Dev. 22, 239-242 (2000).
23. Chamberlain J, Altieri M, Futterman C, Young GM, Ochsenschlager DW, Waisman Y: A prospective randomized study comparing intramuscular midazolam with intravenous diazepam for the treatment of seizures in children. Pediatr. Emerg. Care. 13, 92-94 (1997).
24. Orebaugh SL, Bradford SM: Intravenous versus intramuscular midazolam in treatment of chemically induced generalized seizures in swine. Am. J. Emerg. M Ed. 12, 284-287 (1994).
25. Kendall J, Reynolds M, Goldberg R: Intranasal midazolam in patients with status epilepticus. Ann. Emerg. M Ed. 29, 415-417 (1997).
26. Widler BJ: Effcacy of phenytoin in treatment of status epilepticus. In: Advances in Neurology. Vol. 34. Degaldo-Escueta AV et al. (Eds). Raven Press, NY, USA, 441-446 (1983).
27. Allen FH, Runge RW, Legarda S: Safety, tolerance and pharmacokinetics of intravenous fosphenytoin in status epilepticus. Epilepsia 36 (Suppl. 4), 90-94 (1995).
28. Browne TR, Kugler AR, Eldon MA: Pharmacology and pharmacokinetics of fosphenytoin. Neurology 46 (6 Suppl. 1), S3-S7 (1996).
29. Ramsay RE, DeToledo J: Intravenous administration of fosphenytoin: options for the management of seizures. Neurology 46 (6 Suppl. 1), S17-S19 (1996).
30. Yu KT, Mills S, Thompson N, Cunanan C: Safety and effcacy of intravenous valproate in pediatric status epilepticus and acute repetitive seizures. Epilepsia 44, 724-726 (2003).
31. Olsen KB, Taubøll E, Gjerstad L: Valproate is an effective, well-tolerated drug for treatment of status epilepticus/serial attacks in adults. Acta Neurol. Scand. Suppl. 187, 51-54 (2007).
32. Mehta V, Singhi P, Singhi S: Intravenous sodium valproate versus diazepam infusion for the control of refractory status epilepticus in children: a randomized controlled trial. J. Child Neurol. 22, 1191-1197 (2007).
33. Misra UK, Kalita J, Patel R: Sodium valproate vs phenytoin in status epilepticus: a pilot study. Neurology 67, 340-342 (2006).
34. Agarwal P, Kumar N, Chandra R, Gupta G, Antony AR, Garg N: Randomized study of intravenous valproate and phenytoin in status epilepticus. Seizure 16, 527-532 (2007).
35. Ramael S, Daoust A, Otoul C et al.: Levetiracetam intravenous infusion: a randomized, placebo-controlled safety and pharmacokinetic study. Epilepsia 47, 1128-1135 (2006).
36. Ramael S, De Smedt F, Toublanc N et al.: Single-dose bioavailability of levetiracetam intravenous infusion relative to oral tablets and multiple-dose pharmacokinetics and tolerability of levetiracetam intravenous infusion compared with placebo in healthy subjects. Clin. Ther. 28, 734-744 (2006).
37. Rupprecht S, Franke K, Fitzek S, Witte OW, Hagemann G: Levetiracetam as a treatment option in non-convulsive status epilepticus. Epilepsy Res. 73, 238-244 (2007).
38. Patel NC, Landan IR, Levin J, Szafarski J, Wilner AN: The use of levetiracetam in refractory status epilepticus. Seizure 15, 137-141 (2006).
39. Goraya JS, Khurana DS, Valencia I et al.: Intravenous levetiracetam in children with epilepsy. Pediatr. Neurol. 38, 177-180 (2008).
40. Khurana DS, Kothare SV, Valencia I, Melvin JJ, Legido A: Levetiracetam monotherapy in children with epilepsy. Pediatr. Neurol. 36, 227-230 (2007).
41. Klitgaard H, Matagne A, Gobert J, Wülfert E: Evidence for a unique profle of levetiracetam in rodent models of seizures and epilepsy. Eur. J. Pharmacol. 353, 191-206 (1998).
42. Mazarati AM, Baldwin R, Klitgaard H, Matagne A, Wasterlain CG: Anticonvulsant effects of levetiracetam and levetiracetamdiazepam combinations in experimental status epilepticus. Epilepsy Res. 58, 167-174 (2004).
43. Altenmuller DM, Kuhn A, Surges R, Schulze-Bonhage A: Termination of absence status epilepticus by low-dose intravenous levetiracetam. Epilepsia 49, 1289-1290 (2008).
44. Baulac M, Brodie MJ, Elger CE et al.: Levetiracetam intravenous infusion as an alternative to oral dosing in patients with partial-onset seizures. Epilepsia 48, 589-592 (2007).
45. Kirmani BF, Crisp ED, Kayani S, Rajab H: Role of intravenous levetiracetam in acute seizure management of children. Pediatr. Neurol. 41, 37-39 (2009). •Retrospective review of 32 pediatric epilepsy patients treated with intravenous levetiracetam for acute seizures in the hospital setting. Response was favorable in all patients.
46. Mitchell WG: Status epilepticus and acute repetitive seizures in children, adolescents and young adults: etiology, outcome and treatment. Epilepsia 37 (Suppl. l), S74-S80 (1996).
47. Cereghino JJ, Mitchell WG, Murphy J, Kriel RL, Rosenfeld WE, Trevathan E: Treating repetitive seizures with a rectal diazepam formulation. Neurology 51, 1274-1282 (1998).
48. Kriel RL, Cloyd JC, Hadsall RS, Carlson AM, Floren KL, Jones-Saete CM: Home use of rectal diazepam for cluster and prolonged seizures: effcacy, adverse reactions, quality of life, and cost analysis. Pediatr. Neurol. 7, 713-717 (1991).
49. Dieckmann RA: Rectal diazepam for prehospital pediatric status epilepticus. Ann. Emerg. M Ed. 23, 216-224 (1994).
50. Hayashi K, Osawa M, Aihara M et al.: Effcacy of intravenous midazolam for status epilepticus in childhood. Pediatr. Neurol. 36, 366-372 (2007).